| Sep 3 |
Corcept Shares Rise More Than 45% in Six Months: Here's Why
|
| Aug 28 |
Corcept (CORT) Down 4% Since Last Earnings Report: Can It Rebound?
|
| Aug 27 |
Corcept (CORT) Upgraded to Buy: Here's Why
|
| Aug 19 |
Zacks Industry Outlook Highlights Corcept, Amneal, Bioventus, Foghorn and Akebia
|
| Aug 16 |
Wall Street Analysts Believe Corcept (CORT) Could Rally 70.58%: Here's is How to Trade
|
| Aug 16 |
5 Small Drug Stocks to Buy as Innovation Reaches Peak
|
| Aug 9 |
3 US Growth Companies With High Insider Ownership
|
| Aug 1 |
Corcept Therapeutics Incorporated (CORT) Hits Fresh High: Is There Still Room to Run?
|
| Jul 31 |
Can Corcept (CORT) Run Higher on Rising Earnings Estimates?
|
| Jul 31 |
Are You Looking for a Top Momentum Pick? Why Corcept Therapeutics (CORT) is a Great Choice
|
